|
| . |
|
. |
|
 |
|
|
The 11th Annual Drug Discovery Leaders Summit
| |
Best Practices in European Clinical Trials
9-10 June 2010
Fairmont Le Montreux Palace
Montreux, Switzerland
Congress programme and further information:
www.drugdiscovery-summit.com |
|
|
|
|
The Pharmaceutical industry is experiencing declining productivity and success rates.
To stay competitive, companies are both increasing collaborations and re-evaluating their drug discovery strategies in order to reduce attrition rates at later stages.
Various research and decision-making tools such as enabling technologies, biomarkers, and drug design are being implemented at different stages of the discovery process in order to revitalise efficiency and yield.
Linking data produced during development stages back into discovery to produce translational and personalised medicine is also being utilised to bridge the gap between discovery and development. |
3rd Annual Biomarkers Conference
| |
23-24 March 2010
BSG Conference Centre
London UK
For more information and online registration go to:
www.visiongain.com |
|
|
|
|
Pharmaceutical and biotech companies are looking for new ways to increase the efficiency of drug discovery process while minimising costs and time for approvals. Biomarkers are fast becoming an essential part of clinical development from discovery to approval. According to industry research, the global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7%.
Additionally, the use of proteomics in biomarker testing and identification has boosted the services for biomarkers. A large number of companies now have commercialised biomarker tests employing a variety of technologies. However, there are several barriers and challenges that must be overcome behind these technologies. Visiongain’s 3rd Annual Biomarker Conference will enable you to identify and overcome challenges on how to incorporate biomarkers into your discovery programs as well as highlighting new technologies and strategies to improve prevention and care approaches.
|
Respiratory Disorders 2010
| |
Examining the risk factors for respiratory diseases and assessing the future growth potential of novel therapeutic strategies
10-11 March 2010
BSG Conference Centre
London UK
For more information and online registration go to:
www.visiongain.com |
|
|
|
|
The respiratory disorder market is highly competitive and brings in high revenues. The principal drivers are the increase in disease prevalence and the high economic cost of these diseases. With an increasing patient population and high-profile disorders, this market will continue to grow in the foreseeable future. Visiongain’s inaugural Respiratory Disorders Conference will feature keynote addresses, presentations, case studies and insights from outstanding speakers in this area. The event will showcase recent scientifc developments and significant advances made in COPD, asthma, pulmonary and lung cancer treatments.
Biovays Business Manager, Stéphane Lucchini, will be speaking at the conference on the theme of collaborative partnerships in biomarker assay develoment. He will explore the promises and challenges of biomarkers, innovative approaches to pipeline development and new ways to maximise drug success.
|
Discovery Summit 2010
| |
22-24 March 2010
The Majestic Barrière
Cannes France
For more information and online registration go to:
www.discovery-summit.com |
|
|
|
|
“As the world’s leading drug discovery event, the highly acclaimed 10th Annual Discovery Summit by Marcus Evans offers global perspectives on the challenges of innovative drug discovery and their respective solutions.” *
“Every great advance in science has issued from a new audacity of imagination.” John Dewey *
Determined by continuous research, the programme for the Discovery Summit 2010 explores the key aspects and issues related to the drug discovery industry. The programme provides a robust agenda of keynote and case study presentations, pre-arranged business meetings, workshops and round table discussions. This highly acclaimed 10th edition will examine current and future challenges of innovative drug discovery from a global perspective, offering fresh insight and new solutions.
* www.discovery-summit.com |
5th Annual Biomarkers Congress
|
|
|
|
The pharmaceutical industry is facing high clinical development costs and declining drug discovery success rates.
To stay competitive companies are re-evaluating their drug development process to reduce attrition rates.
Biomarkers promise to transform drug discovery, clinical development and molecular diagnostics in the R&D process as effective use of biomarkers at each stage of R&D
can improve decision-making, increase clinical trial success rates and productivity. |
Biomarker Assay Development
| |
Cambridge Healthtech Institute’s Second Annual Biomarker Assay Development Conference
25-27 January 2010
Hilton San Diego Resort
San Diego, California CA
For more information and online registration go to:
www.healthtech.com |
|
|
|
|
- analytical and biological validation of biomarkers
- multiplex biomarker assays
- protein biomarker assays
- immunoassays
- detection of circulating tumor cells
- novel biomarker assays for cancer
|
San Diego-Nice-Marseille life science conference
| |
Development of Toxicology: New Regulations, New Business Opportunities
26 January 2010 at 6pm
Salk Institute, San Diego
California CA 94304 USA
For more information and online registration go to:
www.frenchbiobeach.com |
|
|
|
|
Good science, smart people
Biovays will be representing the Provence biotech and life science community in the San Diego workshop organised by Provence Promotion and Team Côte d’Azur Economic Development Agencies in partnership with French BioBeach, a San Diego-based networking organisation for US and French biotech communities.
Following the launch of this initiative in San Diego last June, this second workshop marks the consolidation of their partnership and commitment to facilitating long lasting cross-border relationships in the life science sector. Biovays is proud to be invited as one of the five guest companies from the greater Nice-Marseille region selected on the basis of their specialised expertise and innovative research solutions for the cosmetics and pharmaceutical industries. Biovays Business Manager Stéphane Lucchini will be presenting Biomarker Analysis for Predictive Toxicology.
|
Evolution Summit 2009
| |
Best Practices in European Clinical Trials
21-23 October 2009
Fairmont Le Montreux Palace
Montreux, Switzerland
Summit programme and further information:
www.evolution-summit.com |
|
|
|
|
The significant amount of change in the pharmaceutical and biopharmaceutical industry commands the development of fundamentally new approaches to meet the growing needs for drug safety and efficacy more quickly and efficiently. The Evolution Summit addresses the critical challenges of drug development professionals to speed new products to market and constantly stay ahead of the latest decision-making, operational and technology trends.*
“There are no shortcuts in evolution.” Louis D. Brandeis *
* www.evolution-summit.com |
23rd Brazilian Congress of Cosmetology
| |
13th International Trade Fair of Technology for the Cosmetics Industry: FCE Cosmetique 2009
13th International Trade Fair of Technology for the Pharmaceutical Industry: FCE Pharma 2009
26-28 May 2009
Transamercica Expo Center
São Paulo, Brazil
Summit programme and further information:
www.fcecosmetique.com.br |
|
|
|
|
“The most important cosmetology congress in Latin America”, the Brazilian Association of Cosmetology will host the 23rd edition in parallel with two of the continent’s biggest international trade fairs of the cosmetics and pharmaceutical industries – FCE Cosmetics and FCE Pharma 2009.
This year’s theme: Innovation and Sustainability.
Come and join us at “Espaço França” in 2009:
the year of France in Brazil!
|
Discovery Summit 2009
| |
23-25 March 2009
Le Meridien Beach Plaza
Monte-Carlo, Monaco
Summit programme and further information:
www.discovery-summit.com |
|
|
|
|
As the world’s leading drug discovery event, the highly acclaimed 9th Annual Discovery Summit by Marcus Evans offers global perspectives on the challenges of innovative drug discovery and their respective solutions. *
“Discovery is said to be an accident meeting a prepared mind.” **
| * |
www.discovery-summit.com |
| ** |
Albert Szent-Gyorgyil - www.discovery-summit.com |
|
|
|
|
| |
|
|
|
